Overview

Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease

Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
Patients with coronary artery disease have an abnormal cardiac metabolism. The hypothesis of this study is that shifting cardiac metabolism from free fatty acids to glucose will improve myocardial ischemia
Phase:
Phase 4
Details
Lead Sponsor:
IRCCS San Raffaele
Treatments:
Trimetazidine